| ||||
Exclusive Patient Adherence, Communication and Engagement Series - sign up!In the run up to this year’s Patient Summit Europe we’ll be keeping you up to date with all of the best thought leadership pieces and innovations through our exclusive content series…from podcasts to white papers we’ll ensure you’re kept up to speed!Just fill in your details and we’ll send you all of the content in the series so far, as well as keeping you up to date with all of the new releases! The series so far…… May 11th: Dr Mehmood Syed reports on Home Healthcare and adherence...AVAILABLE NOW! April 10th : Bupa Home Healthcare podcast- AVAILBALE NOW! Sarah Strachan, Pharma Partners Development Manager Bupa Home Healthcare talks with us about the challenges of devising a patient programme though collaboration, the different stakeholders input and how to achieve HCP and Patient support throughout. April 1st: Bupa Home Healthcare report-AVAILBALE NOW! Taking the pressure off- the opportunity for home healthcare for todays NHS… This report looks into the case for home healthcare as a solution to better patient care, in terms of adherence, cost and overall patient benefit… March 21st: Quintiles New Health Report-AVAILBALE NOW! Exploring Perceptions of Value and Collaborative Relationships Among Biopharmaceutical Stakeholders by mapping out the complex constellation of stakeholders in pharma—physicians, payers, patients and policy-makers March 19h: Capgemini Consulting Report-AVAILBALE NOW! Patient Adherence: The Next Frontier in Patient Care- this report was created after meticulous case studies form across Europe to determine some of the most commonly asked questions in adherence
Febuary 12th: 2011 Top 3 presentations from 2011-AVAILBALE NOW! To get a taste for our 2012 Patient Summit- listen to three of our top rated presentations from 2011 From Novartis, UCB and Bayer Still to come - exclusive podcasts with Bupa Home Healthcare and Q&A session with Paul Wicks, R&D Director from PatiensLikeMe!
|
||||
| ||||||||||||||||||||||||||||||||||||||||||||||
|